期刊文献+

光动力治疗和冻融对肿瘤细胞抗原释放及树突细胞成熟表型的影响 被引量:2

Effect of tumor antigen released during photodynamic therapy or freezing-thawing on the maturation phenotypes of dendritic ceils
原文传递
导出
摘要 目的探讨光动力疗法(PDT)和冻融导致的肿瘤细胞抗原暴露,对体外树突细胞(DC)成熟表型的影响。方法对体外培养的4T1乳腺癌细胞分别予以PDT和反复冻融,检测4T1细胞的坏死与凋亡,收获上清液并与未成熟DC(imDC)或成熟DC(mDC)共同孵育,采用流式细胞法和激光共聚焦显微镜分析DC免疫表型和形态学特征。结果经两种机制处理的4T1细胞都以坏死为主,但PDT较冻融诱导更高的凋亡率(34.7%±9.6%比16.8%±5.1%,P〈0.05);与上清液孵育后,PDT组imDC的CD80、CD86与I-A/I—E阳性率分另0为22.4%±4.6%、22.5%±5.6%、24.3%±6.3%,冻融组依次为17.3%±3.3%、18.0%±4.7%、20.7%±3.1%,均高于空白对照组(14.2%±3.0%、13.6%±3.3%、15.5%±2.1%,P〈0.05),且PDT组升高更明显,而mDC的免疫表型变化差异无统计学意义(P〉0.05)。结论与冻融相比较,PDT导致更高的细胞凋亡率,更易诱导imDC表达成熟表型。 Objective To investigate the effects of tumor antigen on the maturation phenotypes of dendritic cells through different treatments of antigenic exposure. Methods The necrosis and apoptosis of 4T1 mammary carcinoma cells were detected after an in vitro treatment of photodynamie therapy (PDT) or freezing-thawing. The supernatant of 4T1 cells was harvested and added into the culture of immature or mature dendritic ceils (DCs). The immune phenotypes and morphological features of DCs were analyzed by flow cytometry and eonfoea[ laser scanning microscopy respectively. Results Necrosis predominated after these treatments. But the apoptotie ratio was higher in PDT cells than that in freezing-thawing cells (34. 7% ±9. 6% vs 16. 8% ± 5.1% , P 〈 0. 05 ) . After co-culturing with different supernatants, the immature DCs of PDT group showed more significant increases of positive rates of CD80 (22.4%±4. 6% ) , CD86 (22. 5% ±5.6% ) and I-A/I-E (24. 3% ± 6. 3% ) versus the immature DCs of freezing-thawing group ( 17.3% ± 3.3% , 18.0% ±4.7% and 20. 7% ± 3.1% respectively, P 〈 0. 05 ) and control group (14.2% ± 3. 0% ±13. 6% ±3.3%~15.5% ±2. 1%,P 〈0.05). No difference was found between two groups of mature DCs (P 〉 0. 05 ). Conclusion As compared with the treatment of freezing-thawing, PDT yields a higher apoptotie ratio of 4T1 cells and an elevated expression of maturation phenotypes in imature DCs.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第2期121-124,共4页 National Medical Journal of China
关键词 光化学疗法 细胞凋亡 乳腺肿瘤 树突细胞 免疫表型分型 Photochemotherapy Apoptosis Breast neoplasms Dendritic ceils Immunophenotyping
  • 相关文献

参考文献9

  • 1车巍,周琼,雷铁池,方春红,徐世正.氧对5-氨基酮戊酸光动力疗法诱导HaCaT细胞凋亡和死亡的影响[J].中华皮肤科杂志,2008,41(2):101-104. 被引量:7
  • 2van Duijnhoven FH,Aalbers RI,Rovers JP,et al.The immunological consequences of photodynamic treatment of cancer,a literature review.Immunobiology,2003,207:105-113.
  • 3Qadura M,Othman M,Waters B,et al.Reduction of the immune response to factor Ⅷ mediated through tolerogenic factor Ⅷ presentation by immature dendritic cells.J Thromb Haemost,2008,6:2095-2104.
  • 4Castano AP,Mroz P,Hamblin MR.Photodynamic therapy and anti-tumour immunity.Nat Rev Cancer,2006,6:535-545.
  • 5Castano AP,Liu Q,Hamblin MR.A green fluorescent proteinexpressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.Br J Cancer,2006,94:391-397.
  • 6Zhou F,Xing D,Chen WR.Dynamics and mechanism of HSP70 translocation induced by photodynamic therapy treatment.Cancer Lett,2008,264:135-144.
  • 7Zinser E,Rossner S,Littmann L,et al.Inhibition of the proteasome influences murine and human dendritic cell development in vitro and in vivo.Immunobiology,2009,214:843-851.
  • 8Sur BW,Nguyen P,Sun CH,et al.Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection.Photochem Photobiol,2008,84:1257-1264.
  • 9Nowak-Sliwinska P,Karocki A,Elas M,et al.Verteporfin,photofrin Ⅱ,and merocyanine 540 as PDT photosensitizers against melanoma cells.Biochem Biophys Res Commun,2006,349:549-555.

二级参考文献11

  • 1Kalka K, Merk H, Mukhar H. Photodynamic therapy in dermatology. Am Acad Dermatol, 2000, 42(3 ): 389-413.
  • 2Armenakas A. Laser-mediated photodynamic therapy. Clin Dermatol, 2006, 24( 1 ): 16-25.
  • 3Uebelhoer NS, Dover JS. Photodynamic therapy for cosmetic applications. Dermatol Ther, 2005, 18(3 ): 242-252.
  • 4Busch TM. Local physiological changes during photodynamic therapy. Lasers Surg Med, 2006, 38(5): 494-499.
  • 5Karrer S, Bosserhoff AK, Weiderer P, et al. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol, 2003, 120 (2): 325-331.
  • 6Tsai JC, Wu CL, Chien HF, et al. Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg Med, 2005, 36(5): 398-408.
  • 7Xu S, Wang X, Xu W, et al. Evaluation of photodynamic therapy of skin cancers with δ-aminolevulinic acid. Chin Med Journal, 2002, 115 (8): 1141-1145.
  • 8Kriska T, Korytowski W, Girotti AW, et al. Role of mitochondrial eardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys, 2005, 433(2): 435-446.
  • 9Ji Z, Yang G, Vasovic V, et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B, 2006, 84(3): 213-220.
  • 10Ji Z, Yang G, Shahzidi S, et al. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett, 2006, 244(2): 182-189.

共引文献6

同被引文献38

  • 1孙燕妮,李强,姚小鹏,刘忠令.光动力疗法对人肺腺癌细胞系A549杀伤作用的实验研究[J].中国肺癌杂志,2004,7(5):396-398. 被引量:8
  • 2刘建欣,郑昌学编.现代免疫学[M].北京:清华大学出版社,2002.94.
  • 3Allison R, Moghissi K, Downie G, et al. Photodynamic therapy (PDT) for lung cancer. Photodiagnosis Photodyn Ther, 2011, 8: 231-299.
  • 4Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest, 1982:81 : 269-277.
  • 5Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer, 2003, 3: 380-387.
  • 6Lee JB, Choi JY, Chun JS, et al. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol, 2008, 159 : 61-67.
  • 7Sibani SA, McCarron PA, Woolfson AD, et al. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv, 2008, 5: 1241-1254.
  • 8Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin, 2011, 61 : 250-281.
  • 9Juzeniene A, Nielsen KP, Moan J. Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol, 2006, 25 :7 -28.
  • 10Kato H, Furukawa K, Sato M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl ehlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer, 2003, 42 : 103-111.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部